New You (NWYU) 10-K/A 18 Jun 15 2015 FY Annual report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Feb. 28, 2015	Jun. 10, 2015
Document And Entity Information
Entity Registrant Name	RADIANT CREATIONS GROUP, INC.
Entity Central Index Key	1372184
Document Type	10-K
Document Period End Date	28-Feb-15
Amendment Flag	TRUE
Amendment Description	EXPLANATORY NOTE REGARDING THIS FILING
	Radiant Creations Group, Inc. (“Radiant” or the “Company”) is filing this amended annual report on Form 10-K/A for the fiscal year ended February 28, 2015 in order to include additional disclosures in the Form 10-K originally filed on June 15, 2015 (the “Original 10-K”) related to prior year operations. No changes have been made to the financial statements presented in the Original 10K.
Current Fiscal Year End Date	-26
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float	$700,164
Entity Common Stock, Shares Outstanding	70,016,390	280,464,335
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2015

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Feb. 28, 2015	Feb. 28, 2014
ASSETS
Cash	$15,293	$120,875
Accounts receivable		51,045
Accounts receivable reserve	75,447	72,182
Prepaid expenses and other assets	15,150	8,410
Inventory	39,752	64,701
Total current assets	145,642	317,213
Fixed assets, net of depreciation	8,935	8,968
Total assets	154,577	326,181
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	13,100	16,828
Accrued interest	171,908	74,358
Notes payable - related party	124,237	65,650
ConvertibleB notes payable, current portion	596,515	513,500
Notes payable	135,000	95,000
Derivative liabilities	130,103
Total current liabilities	1,170,863	765,336
LONG-TERM LIABILITIES:
Convertible notes payable, net of discounts and current portion	192,237	730,448
Notes payable	40,000
Total long-term liabilities	232,237	730,448
Total liabilities	1,403,100	1,495,784
DEFICIT
Series A Preferred at $0.00001 par value, 1,000,000 shares authorized, 1,000,000 and -0- issued and outstanding, respectively; Series B Preferred at $0.00001 par value, 100,000,000 shares authorized, 20,000,000 and -0- issued and outstanding, respectively	210
Common stock at $0.00001 par value: 900,000,000 shares authorized, 70,016,390 and 54,271,336 shares issued and outstanding, respectively	700	543
Additional paid-In capital	7,812,010	3,650,743
Accumulated deficit	-9,093,629	-4,820,889
Total Radiant stockholder deficit	-1,280,709	-1,169,603
Non-controlling interest in subsidiary	32,186
Total Deficit	-1,248,523	-1,169,603
TOTAL LIABILITIES AND DEFICIT	154,577	326,181
Preferred Shares Series A
DEFICIT
Series A Preferred at $0.00001 par value, 1,000,000 shares authorized, 1,000,000 and -0- issued and outstanding, respectively; Series B Preferred at $0.00001 par value, 100,000,000 shares authorized, 20,000,000 and -0- issued and outstanding, respectively	10
Total Radiant stockholder deficit	10
Total Deficit	10
TOTAL LIABILITIES AND DEFICIT	10
Preferred Shares Series B
DEFICIT
Series A Preferred at $0.00001 par value, 1,000,000 shares authorized, 1,000,000 and -0- issued and outstanding, respectively; Series B Preferred at $0.00001 par value, 100,000,000 shares authorized, 20,000,000 and -0- issued and outstanding, respectively	200
Total Radiant stockholder deficit	200
Total Deficit	200
TOTAL LIABILITIES AND DEFICIT	$200

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Feb. 28, 2015	Feb. 28, 2014
Preferred stock, par value per share	$0.00
Preferred stock, shares authorized	100,000,000
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	900,000,000	900,000,000
Common stock, shares issued	70,016,390	54,271,336
Common stock, shares outstanding	70,016,390	54,271,336
Preferred Shares Series A
Preferred stock, shares issued	1,000,000	0
Preferred stock, shares outstanding	1,000,000	0
Preferred Shares Series B
Preferred stock, shares issued	20,000,000	0
Preferred stock, shares outstanding	20,000,000	0

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Income Statement [Abstract]
REVENUES	$526,652	$648,678
COST OF SERVICES	64,603	112,440
GROSS PROFIT	462,049	536,238
Operating Expenses:
General and administrative expenses (includes stock based compensation of $3,212,910 and $10,000, respectively)	4,147,709	1,412,837
Depreciation	1,800	1,050
Inventory write-off	3,676	31,223
License write-off		1,000,000
Other intangibles write-off		350,000
Total operating expenses	4,153,185	2,795,110
Operating loss	-3,691,136	-2,258,872
Other Income (Expense):
Interest expense	628,110	1,277,320
Bad debt recovery	195,534
Loss on purchase of intellectual property from related party	726,400
Gain/(loss) on derivative liabilities	609,558	-280,760
Total other expense, net	-549,418	-1,558,080
LOSS FROM OPERATIONS	-4,240,554	-3,816,952
LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST IN SUBSIDIARY	32,186
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	($4,272,740)	($3,816,952)
NET LOSS PER COMMON SHAREB - Basic and Diluted	($0.08)	($0.09)
Weighted Common Shares OutstandingB B - Basic and Diluted	50,286,581	41,420,314

Consolidated_Statements_Of_Ope1

Consolidated Statements Of Operations (Parenthetical) (USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Income Statement [Abstract]
Stock based compensation	$3,212,910	$10,000

Consolidated_Statement_Of_Defi

Consolidated Statement Of Deficit (USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2013
Balance common shares	54,271,336
Balance value	($1,169,603)	($870,887)
Issuance of Common Stock for Cash, value		1,388,700
Issuance of Common Stock as Compensation, value		10,000
Capital contribution		2,000
Issuance of Common Stock for Acquisition of Assets, value		944,530
Excess of FV Over Assets Acquired		564,628
Common stock issued for conversion of debt, value	215,150	204,404
Reclassification of derivative to additional paid in capital upon conversion of debt	107,172	1,433,974
Common stock repurchased, value		1,030,000
Common stock issued for services, value	19,524
Cancellation of common stock, value
Stock based compensation	3,193,006	564,628
Preferred stock issued, value	476,400
Issuance of common stock of subsidiary	150,382
Net Loss for the year	-4,272,740	-3,816,952
Balance common shares	70,016,390	54,271,336
Balance Value	-1,248,523	-1,169,603
Preferred Shares Series A
Preferred stock issued, shares	1,000,000
Preferred stock issued, value	10
Net Loss for the year
Balance preferred shares	1,000,000
Balance Value	10
Preferred Shares Series B
Preferred stock issued, shares	20,000,000
Preferred stock issued, value	200
Net Loss for the year
Balance preferred shares	20,000,000
Balance Value	200
Common Stock
Balance common shares	54,271,336	30,000,000
Balance value	543	300
Issuance of Common Stock for Cash, shares		20,657,439
Issuance of Common Stock for Cash, value		207
Issuance of Common Stock as Compensation, shares		200,000
Issuance of Common Stock as Compensation, value		2
Capital contribution
Issuance of Common Stock for Acquisition of Assets, shares		7,545,788
Issuance of Common Stock for Acquisition of Assets, value		75
Excess of FV Over Assets Acquired
Common stock issued for conversion of debt, shares	32,005,054	3,413,897
Common stock issued for conversion of debt, value	320	34
Reclassification of derivative to additional paid in capital upon conversion of debt
Common stock repurchased, shares		-7,545,788
Common stock repurchased, value		75
Common stock issued for services, shares	3,740,000
Common stock issued for services, value	37
Cancellation of common stock, shares	-20,000,000
Cancellation of common stock, value	-200
Net Loss for the year
Balance common shares	70,016,390	54,271,336
Balance Value	700	543
Additional Paid in Capital
Balance value	3,650,743	132,750
Issuance of Common Stock for Cash, value		1,388,493
Issuance of Common Stock as Compensation, value		9,998
Capital contribution		2,000
Issuance of Common Stock for Acquisition of Assets, value		944,455
Excess of FV Over Assets Acquired		564,628
Common stock issued for conversion of debt, value	214,830	204,370
Reclassification of derivative to additional paid in capital upon conversion of debt	107,172	1,433,974
Common stock repurchased, value		1,029,925
Common stock issued for services, value	19,487
Cancellation of common stock, value	200
Stock based compensation	3,193,006
Preferred stock issued, value	476,190
Issuance of common stock of subsidiary	150,382
Net Loss for the year
Balance Value	7,812,010	3,650,743
Accumulated Deficit
Balance value	-4,820,889	-1,003,937
Issuance of Common Stock for Cash, value
Issuance of Common Stock as Compensation, value
Capital contribution
Issuance of Common Stock for Acquisition of Assets, value
Excess of FV Over Assets Acquired
Common stock issued for conversion of debt, value
Reclassification of derivative to additional paid in capital upon conversion of debt
Common stock repurchased, value
Cancellation of common stock, value
Stock based compensation
Preferred stock issued, value
Net Loss for the year	-4,240,554	-3,816,952
Balance Value	-9,093,629	-4,820,889
Non-controlling Interest
Balance value
Stock based compensation
Net Loss for the year	32,186
Balance Value	$32,186

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	($4,240,554)	($3,816,952)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense	1,800	1,050
Loss on purchase of intellectual property from a related party	726,400
(Gain/)Loss on derivative liabilities	609,558	-280,760
Amortization of debt discounts	618,110	1,153,214
Default interest added to convertible notes payable	10,000
Excess fair value of asset purchase- compensation		564,628
Stock based compensation	3,212,910	10,000
Write off of inventory	3,676	31,223
Write off of intangible asset	210	1,350,000
Bad debt recovery	195,534
Changes in operating assets and liabilities:
Inventory	-24,949	31,394
Accounts receivable	-51,045	51,045
Reserves	3,265	72,182
Prepaid expenses and other current assets	6,740	8,410
Accounts payable and accrued interest	150,786	146,568
NET CASH USED IN OPERATING ACTIVITIES	-255,764	-442,540
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of Fixed Assets	1,767	10,018
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash borrowings from convertible debt	110,440	143,500
Cash payments on convertible debt	31,000
Cash borrowings from related parties	12,493	153,250
Cash payments on related party debt	129,986	87,600
Cash borrowings from notes payable	50,000
Cash payments on notes payable	10,000	5,000
Capital contribution		2,000
Cash proceeds from sale of common stock of subsidiary	150,002
Cash paid for the repurchase of common shares		1,030,000
Cash proceeds from issuance of common shares		1,388,700
NET CASH PROVIDED BY FINANCING ACTIVITIES	151,949	564,850
NET CHANGE IN CASH	-105,582	112,292
Cash at Beginning of Year	120,875	8,583
Cash at End of Year	15,293	120,875
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	42,250	21,769
Cash paid for income taxes
NON-CASH FINANCING AND INVESTMENT ACTIVITIES:
Acquisition of Assets from The Renewable Corp.		1,509,158
Debt discount	507,211
Conversion of convertible debt and accounts payable to common shares	215,150	204,404
Reclassification of derivative to additional paid in capital	107,172	1,433,974
Assignment and modification of notes payable		900,448
Issuance of preferred stock in exchange for common stock	$476,400

Organization_And_Significant_A

Organization And Significant Accounting Policies	12 Months Ended
	Feb. 28, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	NOTE 1 – Organization and Significant Accounting Policies
	Nature of Business
	On June 20, 2013, following a change of control and subsequent acquisition of an exclusive license agreement, certain assets and processes to innovative technologies in skin protection and enhancement, which consist of various proprietary products including an anti-aging and revitalizing skin cream generally sold under the "Radiant Creations" label, the Company changed its principal business to the development and marketing of unique and proprietary scientific technologies and cosmetic and over-the-counter personal enhancement products and devices. The Company currently sells its products exclusively over the internet to customers located globally.
	Basis of Presentation
	The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission.
	Principles of consolidation
	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
	Non-controlling interest in consolidated financial statements
	Accounting guidance on non-controlling interests in consolidated financial statements requires that a non-controlling interest in the equity of a subsidiary be accounted for and reported as equity and provides revised guidance on the treatment of net income and losses attributable to the non-controlling interest and changes in ownership interests in a subsidiary. The revised guidance requires additional disclosures that identify and distinguish between the interests of the controlling and non-controlling owners.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include the valuation of stock-based compensation and derivative liabilities.
	Fair Value of Financial Instruments
	Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis.
	As February 28, 2015:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
		$	—	$	—	$	130,103	$	130,103
	Embedded conversion derivative liability
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents.
	Inventory
	Inventory consists of finished goods and is valued at the lower of cost or market value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow moving inventory is made based on management analysis or inventory levels and future sales forecasts.
	Property and Equipment
	Property and equipment are stated at cost, net of depreciation provided by use of a straight-line method over the estimated useful lives of the assets, of five years. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable.
	Basic and diluted net loss per share
	Basic loss per share is computed using the weighted average number of shares of common stock outstanding during each period. Diluted loss per share includes the dilutive effects of common stock equivalents on an “as if converted” basis. For the twelve months ended February 28, 2015, the number of potentially dilutive shares consisted of 191,333,593 shares underlying convertible debt as well as options to acquire 38,050,000 shares. For the twelve months ended February 28, 2014, the number of potentially dilutive shares consisted of 14,672,640 shares underlying the debt that was convertible as of February 28, 2014. For the years ended February 28, 2015 and 2014, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
	Related parties
	The Company follows subtopic ASC 850, Related Party Disclosure, for the identification of related parties and disclosure of related party transactions.
	Revenue Recognition
	The Company follows guidance under ASC 605, Revenue Recognition, in determining when to report income from operations. The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured. Revenue recognized by the Company normally occurs upon shipment of our product to the customer.
	Cost of Revenue
	Amounts recorded as cost of revenue relate to direct expenses incurred in order to fulfill orders of our products. Such costs are recorded as incurred. Our cost of revenue consists primarily of the cost of product; payment processing fees; and the cost of product samples.
	Cash flows reporting
	The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period.
	Advertising
	The Company follows guidance found under ASC 340, Other Assets and Deferred Costs, and ASC 720-35, Other Expenses – Advertising Costs, when discerning whether advertising costs should be capitalized or expensed as incurred. Although U.S. GAAP permits the allocation of advertising costs across interim periods within a fiscal year when future periods benefit from the expenditure, the Company’s policy is to expense advertising costs as incurred to eliminate the uncertainty in estimating overall expected sales volumes, advertising expenses, and the benefit period of the advertising on an interim basis due to the immateriality and nature of those costs at this time.
	Share-based Expense
	ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).
	The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.
	Share-based expense for the twelve month periods ending February 28, 2015and 2014 was $3,212,910 and $10,000, respectively.
	Income Taxes
	The Company utilizes the asset and liability method to measure and record deferred income tax assets and liabilities. Deferred tax assets and liabilities reflect the future income tax effects of temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and are measured using enacted tax rates that apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
	The Company follows the provisions of Accounting for Uncertainty in Income Taxes, which clarified the accounting for uncertainties in tax positions and required that the Company recognizes in its financial statements the impact of an uncertain tax position, if that position has more likely than not chance of not being sustained on audit, based on technical merits of that position.
	The Company is subject to the United States federal and state income tax examinations by the tax authorities for the 2014, 2013, and 2012 tax years.
	Recently issued accounting pronouncements
	We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operations, financial position or cash flow.
	In January 2015, FASB issued Accounting Standards Update (ASU) No. 2015-01 Income Statement—Extraordinary and Unusual Items. This Update eliminates from GAAP the concept of extraordinary items. Subtopic 225-20, Income Statement—Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions. Presently, an event or transaction is presumed to be an ordinary and usual activity of the reporting entity unless evidence clearly supports its classification as an extraordinary item. Paragraph 225-20-45-2 contains the following criteria that must both be met for extraordinary classification: 1. Unusual Nature. The underlying event or transaction should possess a high degree of abnormality and be of a type clearly unrelated to, or only incidentally related to, the ordinary and typical activities of the entity, taking into account the environment in which the entity operates. 2. Infrequency of Occurrence. The underlying event or transaction should be of a type that would not reasonably be expected to recur in the foreseeable future, taking into account the environment in which the entity operates. If an event or transaction meets the criteria for extraordinary classification, an entity is required to segregate the extraordinary item from the results of ordinary operations and show the item separately in the income statement, net of tax, after income from continuing operations. The entity also is required to disclose applicable income taxes and either present or disclose earnings-per-share data applicable to the extraordinary item.
	In August 2014, FASB issued Accounting Standards Update (ASU) No. 2014-15 Preparation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. Under generally accepted accounting principles (GAAP), continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, Presentation of Financial Statements—Liquidation Basis of Accounting. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the amendments in this Update should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company will evaluate the going concern considerations in this ASU however, for the current period, management does not believe that it has met conditions which would subject these financial statements to additional disclosure.
	In June 2014, FASB issued Accounting Standards Update (ASU) No. 2014-12 Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award’s grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after 15 December 2015 and interim periods within those annual periods. Early adoption is permitted. Management has reviewed the ASU and believes that they currently account for these awards in a manner consistent with the new guidance; therefore there is no anticipation of any effect to the financial statements.

Going_Concern

Going Concern	12 Months Ended
	Feb. 28, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – Going Concern
	The accompanying financial statements have been prepared on the basis of accounting principles applicable to a “going concern”, which assume that the Company will continue in operation for at least one year and will be able to realize its assets and discharge its liabilities in the normal course of operations.
	Several conditions and events cast substantial doubt about the Company’s ability to continue as a going concern. The Company has a working capital deficit of $1,025,221 and has incurred net losses since inception. The Company’s future capital requirements will depend on numerous factors including, but not limited to, executing its marketing and business plans and the pursuit of business opportunities. The Company is actively pursuing alternative financing and has had discussions with various third parties, although no firm commitments have been obtained. In the interim, shareholders of the Company have committed to meeting its operating expenses. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.
	These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Acquisition

Acquisition	12 Months Ended
	Feb. 28, 2015
Business Combinations [Abstract]
Acquisition	NOTE 3 – Acquisition
	On June 25, 2013, we purchased certain assets from The Renewable Corporation. The purchase price consisted of 6,805,556 common shares fair valued at $.20 per share. The purchases included their license, certain assets and processes to innovative technologies in skin protection and enhancement which consists of proprietary products including an anti-aging and revitalizing skin cream to be marketed generally under the "Radiant Creations" label. On July 10, 2013 the purchase price was increased to 7,545,788 shares fair valued at $.20 per share. The purchase price was restructured to include assumption of additional Renewable debt by Radiant. A summary of the assets and liabilities acquired are shown below:
	Purchase Price
	Stock	$	1,509,158
	Assets Acquired
	Inventory		64,530
	Nucleotide documentation		350,000
	License		1,000,000
	Convertible debentures		(370,000	)
	Promissory notes		(100,000	)
	Total value	$	944,530
	The excess of the fair value of consideration over the assets acquired of $564,628 was recorded to stock compensation because the entities are related parties. The entities are not under common control; however, the entities share the same CEO and CFO.

Notes_Payable

Notes Payable	12 Months Ended
	Feb. 28, 2015
DisclosureShorttermConvertibleNotePayableAbstract
Notes Payable	NOTE 4 –Notes Payable
	Notes payable – third parties
	The Company has two notes with outstanding balances as of February 28, 2015 of $75,000 and $10,000 which are subject to annual interest of 15% and matured on November 29, 2014 and January 31, 2015, respectively.
	In July 2014, the Company issued a note payable in the amount of $40,000 for cash. The note matures in 36 months and accrues interest at an annual rate of 10%, payable quarterly.
	In October 2014, the Company issued a demand note in the amount of $50,000 for cash. The note is due on demand and accrues interest at an annual rate of 12%.
	Notes payable - related parties
	As of February 28, 2014 the Company had advances from corporate officers of $15,650. The advances were non-interest bearing and due on demand. These advances were fully paid as of February 28, 2015.
	On February 3, 2014, the Company received an advance from a corporate officer of $50,000. The note was subject to annual interest of 15% and matured on February 28, 2015. As of February 28, 2015, the note was paid in full.
	In July 2014, the Company issued a note payable in the aggregate amount of $250,000 for the purchase of intellectual property from a commonly owned entity. Because of the common ownership, the intellectual property was not marked to fair value and the Company recognized a loss for the amount of the notes, which is included in loss on acquisition of intellectual property from a commonly controlled entity on the consolidated statements of operations. The note is non-interest bearing, matures in 24 months from issuance, and requires principal payments of at least $25,000 every 180 days. As of February 28, 2015, the outstanding balance of the note was $116,337.
	In September 2014, the Company issued a note in the amount of $7,900 for cash. The note is payable in two years from issuance, and accrues interest, payable monthly, at an annual rate of 10%. The balance of the note is $7,900 as of February 28, 2015.

Convertible_Notes_Payable

Convertible Notes Payable	12 Months Ended
	Feb. 28, 2015
Convertible Notes Payable
Convertible Notes Payable	NOTE 5 – Convertible Notes Payable
	Note	Maturity Date	Face	Eligible for Conversion	Conversion	Amounts	Balance
	Date		Amount		Date	Converted / Cash Paid*	Outstanding
	5/21/13	9/20/16	$900,448	6/15/13	N/A	$31,000*	$869,448
					9/19/13	$100,000	$769,448
					11/20/13	$70,000	$699,448
	6/27/13	- $100,000 due 12/12/2014	370,000	6/27/13	-	-	$370,000
		-$270,000 no due date
	11/19/13	8/21/14	$78,500	5/19/14	6/13/14	$12,000	$66,500
					7/1/14	$12,000	$54,500
					7/11/14	$15,000	$39,500
					7/21/14	$19,500	$20,000
			$10,000				$30,000
			Default
					11/19/14	$7,235	$22,765
					12/1/14	$5,635	$17,130
					12/12/14	$6,395	$10,735
					12/16/14	$5,780	$4,955
					1/23/15	$4,955	$ -0-
	12/17/13	9/21/14	$32,500	6/15/14	N/A	$4,430	$32,500
			$16,250			$6,030	$48,750
			Default		2/2/15		$44,320
					2/5/15		$38,290
	1/27/14	10/29/14	$32,500	7/26/14	-	-	$32,500
			$16,250				$48,750
			Default
	7/8/14	4/9/15	$21,150	1/4/15	-	-	$21,150
			$10,575				$31,725
			Default
	9/3/14	6/5/15	$32,500	3/3/15	-	-	$32,500
			$16,250				$48,750
			Default
	9/10/14	9/10/16	$35,000	9/10/14	-	-	$35,000
	1/12/15	10/14/15	$16,000	7/11/15	-	-	$16,000
			$8,000				$24,000
			Default
	Totals		$1,595,923	-	-	$299,960	$1,295,963
	Convertible notes payable – third parties
	During 2011, 2012 and 2013, 2 third parties loaned the Company $720,000. These loans were unsecured. These loans (including accrued interest of $140,448) in the amount of $900,448 were converted to a Convertible Note Payable due to Southwest Financial bearing interest at 10% per annum. Following the conversions to common stock of $170,000 later in fiscal 2015, the Company owed $730,448 principal plus $57,132 in accrued interest as of February 28, 2014. During fiscal 2014, the notes were convertible at the option of the Holder at fixed rate of $0.075 per share. The maturity date of the notes is September 20, 2015. In fiscal 2015, the notes are convertible at a fixed rate of $0.003 per share. Principal cash payments on these notes during the twelve months ended February 28, 2015 amounted to $31,000. As disclosed above, this note was deemed tainted on the date that the other convertible notes became convertible on May 18, 2014. A derivative liability of $252,313 was recorded as a debt discount and amortized over the term of the note. The principle balance of the note was $699,448 as of February 28, 2015.
	As of February 28, 2015 and 2014, the Company owed convertible notes totaling $370,000 to third parties including accrued interest of another $4,041. Interest is 10% annually and is to be paid currently. The notes may be converted at the option of the Holder at a fixed rate of $0.075 per share. As disclosed above, these notes were deemed tainted on the date that the other note became convertible on May 18, 2014. A net derivative liability of $148,771 was recorded as a debt discount to be amortized over the terms of the notes. The principle balance of the notes as of February 28, 2015 was $370,000 whereby $100,000 matured on December 12, 2014 and the remaining balance of $270,000 is due on demand.
	On November 19, 2013, the Company signed a convertible note agreement with a third party in which the party loaned $78,500 subject to annual interest of 8%. The note matured on August 21, 2014 and was convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On May 18, 2014, the note became convertible and the embedded conversion option required derivative accounting for the variable conversion rate. On May 18, 2014, a derivative liability of $64,146 was recorded as a debt discount and amortized over the term of the note. The embedded conversion option of the note also tainted the other outstanding convertible notes. During the twelve months ended February 28, 2015, the lender converted $78,500 in principle and $10,000 in default interest in exchange for 10,540,476 shares of common stock and the note has been paid in full.
	On December 17, 2013, the Company signed a convertible note agreement with a third party in which the party loaned $32,500 subject to annual interest of 8%. The note matured on September 21, 2014 and is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On June 25, 2014, the note became convertible and the embedded conversion option required derivative accounting for the variable conversion rate. On June 25, 2014, a derivative liability of $25,723 was recorded as a debt discount and amortized over the term of the note. The embedded conversion option of the note also tainted the outstanding convertible notes. On December 1, 2014, default interest in the amount of $16,250 was added to the principle balance of the note. During the twelve months ended February 28, 2015, the lender converted $10,460 in principle in exchange for 8,716,667 shares of common stock. The principle balance of the note was $38,290 as of February 28, 2015.
	On January 27, 2014, the Company signed a convertible note agreement with a third party in which the party loaned $32,500 subject to annual interest of 8%. The note matured on October 29, 2014 and is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On July 26, 2014, the note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate. On July 26, 2014, a derivative liability of $23,228 was recorded as a debt discount and amortized over the term of the note. The embedded conversion option of the note also tainted the outstanding convertible notes. During the three months ended February 28, 2015, default interest of $16,250 was added to the principle balance of the note and an additional derivative liability of $11,014 was recorded. The principle balance of the note was $48,750 as of February 28, 2015.
	On July 8, 2014, the Company signed a convertible note agreement with a third party in which the party loaned $21,150 subject to annual interest of 8%. The note matures on April 9, 2015 and is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On January 4, 2015, the note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate. On January 4, 2015, a derivative liability of $11,138 was recorded as a debt discount to be amortized over the term of the note. The embedded conversion option of the note also tainted the outstanding convertible notes. During the three months ended February 28, 2015, default interest of $10,575 was added to the principle balance of the note and an additional derivative liability of $7,136 was recorded. The principle balance of the note as of February 28, 2015 was $31,275.
	On September 3, 2014, the Company signed a convertible note agreement with a third party in which the party loaned $32,500 subject to annual interest of 8%. The note matures on June 5, 2015 and is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On March 2, 2015, the note became convertible and the embedded conversion option will require derivative accounting due to the variable conversion rate. During the three months ended February 28, 2015, default interest of $16,250 was added to the principle balance of the note and an additional derivative liability of $9,264 was recorded. The principle balance of the note as of February 28, 2015 was $48,750.
	On September 9, 2014, the Company executed a $200,000 Convertible Promissory Note bearing interest on the unpaid balance at the rate of 12% on the original principal amount. The principle amount due on the note shall be prorated based upon the consideration actually received by the Company, plus an approximate 10% original issue discount that is prorated based upon the consideration actually received as well as any other interest or fees. Under the terms of the note, the Company is not required to repay any unfunded portion of the note. The Maturity Date is two years from the Effective Date of each payment and is the date upon which the principal sum of this Note, as well as any unpaid interest and other fees, shall be due and payable. The conversion price is the lesser of $0.045 or 60% of the lowest trade price in the 25 trading days previous to the conversion. The balance of the note as of February 28, 2015 is $35,000.
	On January 12, 2015, the Company signed a convertible note agreement with a third party in which the party loaned $16,000 subject to annual interest of 8%. The note matures on October 14, 2015 and is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion. On July 11, 2015, the note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate. During the three months ended February 28, 2015, default interest of $8,000 was added to the principle balance of the note and an additional derivative liability of $4,636 was recorded. The principle balance of the note as of February 28, 2015 was $24,000.
	During the twelve months ended February 28, 2015, the Company entered into convertible liabilities with certain individuals (referred to as the "the Holders"), the Company/Holders/Debtors assigned, converted, and issued Convertible Liability (the “Convertible Liability" or “Liability”) with a $240,000 principal amount. The Liability bear an interest rate of 0% per annum and no maturity date under to a Settlement and Stipulation Agreement; and Court Ordered Approval Document, the Holder has the right to convert all or any part of the outstanding and unpaid principal into shares of the Company’s common stock. On October 2016, 2014, the US Court ordered approval of the liability triggered derivative treatment. The Holders have the right from and after the court ordered dated, and until any time until the Liability is fully paid, to convert any outstanding and unpaid principal portion of the Liability, into fully paid and non-assessable shares of Common Stock. The Convertible Liability is convertible at variable conversion prices at 55% of lowest trading prices over 15 trading days with no reset provisions. The Company recorded an initial derivative liability and expense of $253,401. In October 2014, the holder of the note agreed to consider the note cancelled in exchange for consideration of $19,524. In October and November 2014, the Company issued 3,740,000 shares of common stock for a value of $19,524, thereby satisfying the terms of the cancellation of the note.
	Amortization expense on the debt discounts for the twelve months ended February 28, 2015 amounted to $618,110 and notes are carried at $788,752, net of unamortized discounts of $507,211. For the twelve months ended February 28, 2014, amortization expense on debt discounts was $1,153,214.

Derivative_Liabilities

Derivative Liabilities	12 Months Ended
	Feb. 28, 2015
DisclosureChangeOfControlAbstract
Derivative Liabilities	NOTE 6– Derivative Liabilities
	The Company records the fair value of the of the conversion features of the convertible notes disclosed in Note 5 in accordance with ASC 815, Derivatives and Hedging. The fair value of the derivative liability was calculated using a multi-nominal lattice model. The fair value of the derivative liability is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. During the twelve months ended February 28, 2015 and 2014, the Company recorded a gain on the change in fair value of derivative liabilities of $376,332 and a loss on the change in fair value of derivative liabilities of $280,760, respectively.
	The following table summarizes the changes in derivative liabilities during the twelve months ended February 28, 2015:
	Balance as of February 28, 2014	$                   -0-
	Fair value of embedded conversion derivative liability at issuance	846,833
	Reclassification of derivatives upon conversion of convertible debt	-107,172
	Unrealized derivatives gains included in other expense	-609,558
	Ending balance as of February 28, 2015	$           130,103
	The Company determined that the instruments embedded in the convertible note should be classified as liabilities and recorded at fair value due to their being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The fair value of the instruments was determined using multinomial lattice model based on the following assumptions:
		-	The projected volatility curve for each valuation period was based on the historical volatility of the Company and ranged from 191% to 198%.
		-	An event of default would occur 5% of the time, increasing 1.00% per month to a maximum of 10%,
		-	The monthly trading volume would average $175,000 to $136,000 and would increase at 1% per month. The variable conversion price of 58% of ask-bid or close prices over 10 trading days have an effective discount rates of 42.42%,
		-	The variable conversion price of the lesser of: (i) $0.045, or (ii) 60% of the lowest trade price over 25 trading days would have an effective discount rates of 47.92% to 47.64%
		-	The Note Holders would automatically convert fixed and variable conversion prices (with full ratchet resets) the notes at the stock price for the convertible Note if the registration was effective and the Company was not in default, and conversion price reset events are assumed every 3 months.
	The following table summarizes the changes in derivative liabilities during the twelve months ended February 28, 2014:
	Ending balance as of February 28, 2013	$                   -0-
	Additions due to new convertible debt issued	1,161,574
	Day one loss on derivative	-8,360
	Resolution of Derivative to Equity due to conversion and modification	-1,433,974
	(Gain)/loss on change in fair value	280,760
	Ending balance as of February 28, 2014	$                   -0-
	The Company determined that the instruments embedded in the convertible note should be classified as liabilities and recorded at fair value due to their being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The fair value of the instruments was determined using multinomial lattice model based on the following assumptions:
	-  The projected volatility curve for each valuation period was based on the historical volatility of the Company.
	-  1 to 5-year Volatility 198%-431%,
	-  An event of default would occur 5% of the time, increasing 1.00% per month to a maximum of 10%,
	-  The monthly trading volume would average $100,000 to $135,600 and would increase at 1% per month. The variable conversion prices 50% of ask-bid or close prices over 3 to 10 trading days have effective discount rates of 31.75% to 49.13%,
	-  The Note Holders would automatically convert variable conversion prices 50% of ask-bid or close prices over 3 to 10 (with full ratchet resets) the notes at the stock price for the Convertible Note if the registration was effective and the Company was not in default, and Conversion price reset events are assumed every 3 months.
	Prior to November 29, 2013, the convertible note for $730,448 discussed in Note 5 was convertible at a variable rate of 50% of the lowest prior three trading days. On February 27, 2014, the Company modified the convertible note to a fixed conversion rate of $0.075. On November 29, 2014, the Company further modified this convertible note to remove the ratchet provision and extend the maturity date from August 20, 2014 to September 20, 2015. The Company determined that under ASC 470-50-40-11, the modification of the conversion price and the removal of the ratchet provision did not qualify as debt extinguishment because the convertible note was considered to be a derivative prior to the modification date. The Company analyzed the modification of the maturity date under ASC 470 and concluded that the modification did not qualify as a substantial modification under ASC 470-50 and therefore the revised terms did not qualify as extinguishment of debt.
	Prior to February 24, 2014, the convertible notes of $370,000 disclosed in Note 5 were convertible at the option of the Holder at a rate of 50% of the average of the previous 5 days closing price on the common stock. The embedded conversion options were classified as liabilities under ASC 815. On February 24, 2014 and February 26, 2014, the Company modified these convertible notes to remove the variable conversion price to a fixed conversion price of $0.075. There were no other terms or features of these convertible notes that qualified as an embedded derivative under ASC 815. Further, the Company determined that the modification did not qualify as debt extinguishment under ASC 470-50-40-11 as the notes were considered to be derivatives prior to and as of the date of modification.
	As a result of the above modifications, the Company fair valued the convertible notes on the date of modification and recorded a loss due to change in fair value of the derivative and recorded the resolution of the derivative to additional paid-in capital. As of February 28, 2014, none of the convertible notes were considered to have an embedded derivative under ASC 815.

Equity

Equity	12 Months Ended
	Feb. 28, 2015
Equity [Abstract]
Equity	NOTE 7 – Equity
	During the twelve months ended February 28, 2014, the Company sold 20,657,439 common shares for proceeds of $1,388,700.
	During the twelve months ended February 28, 2014, the Company issued 200,000 common shares for services valued at $0.05 per share.
	During the twelve months ended February 28, 2014, the former CEO paid $2,000 for expensed on behalf of the Company. This transaction has been accounted for as a contribution of capital.
	During the twelve months ended February 28, 2014, the Company repurchased 7,545,788 common shares from The Renewable Corporation in exchange for cash of $1,030,000.
	During the twelve months ended February 28, 2014, the Company issued 2,933,333 common shares for the conversion of debt of $170,000 at a conversion rate of $0.05 per share.
	During the twelve months ended February 28, 2014, the Company issued 480,564 common shares to a related party for the conversion of accounts payable at conversion rates between $0.05 and $0.095.
	On September 9, 2014 and October 13, 2014 Biodynamic Molecular Technologies, LLC (a commonly controlled shareholder) agreed to cancel a total of 20,000,000 common shares of the Company in exchange for 1,000,000 shares of Series A Preferred stock and 20,000,000 shares of Series B Preferred stock.
	On October 10, 2014, the Board of Directors agreed to designate a series of preferred shares (the Series A Super Voting Preferred Shares) including 1,000,000 (non-convertible) shares containing the following preferential provision:
	Holders of each Series A Preferred Stock shall have two hundred (200) times the number of votes on all matters submitted to the shareholders that each shareholder of the Corporation’s Common Stock (rounded to the nearest whole number) is entitled to vote at each meeting of the shareholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the shareholders of the Corporation for their action or consideration. Holders of the Series A Preferred Stock shall vote together with the holders of Common Stock as a single class.
	On October 13, 2014, the Board of Directors agreed to designate a series of preferred shares (the Series B Preferred Shares) including 20,000,000 (non-convertible) shares containing the following preferential provisions:
	Except as specifically provided, the Series B Preferred Stock shall, with respect to rights on redemption and rights on liquidation, winding up and dissolution, rank senior to (i) all classes of Common Stock, $0.00001 par value per share, of the Company (the “Common Stock”) and (ii) any class or series of capital stock of the Company hereafter created (unless, with the consent of the Holder(s) of Series B Preferred Stock). All other provisions remain paripassu as to the Company's common stock.
	The Company estimated the fair value of the 20,000,000 shares of common stock based on the trading price on date of the exchange, and the fair value of the preferred stock using a probability weighted expected return method (PWERM) and recorded expense equal to the excess of the fair value of the preferred stock over the common stock of $476,400, which is included in loss on acquisition of intellectual property from a commonly controlled entity on the condensed consolidated statements of operations.
	During the twelve months ended February 28, 2015, the Company issued 32,005,054 shares of common stock upon the conversion of debt, for an aggregate value of $215,150. (see Note 5)
	During the twelve months ended February 28, 2015, the Company issued 3,740,000 shares of common stock as compensation for services for a value of $19,524.
	During the twelve months ended February 28, 2015, the Company granted 38,050,000 options to employees and directors with a term of 5 years and are exercisable at prices ranging from $0.098 to $0.127 per share. 10,000,000 options vested immediately while the remaining 28,050,000 options vest at a rate of 33% on the grant date, 33% one year from the grant date and the remaining 33% two years from the grant date. The fair value of the options was determined using a Black Scholes model. The total grant date fair value of the options amounted to $4,502,234 of which $3,193,006 was recorded as stock compensation expense during the twelve months ended February 28, 2015.
	Stock compensation expense totaled $3,212,910 for the twelve months ended February 28, 2015.
	The assumptions used in the Black Scholes valuations include:
		-	Volatility: 188% to 288%
		-	Risk-free interest rate: 0.38% to 0.94%
		-	Zero expected dividends
		-	Expected term is the simplified method
		-	Exercise prices are based on option agreements
		-	Common stock price on the valuation date
	The following tables summarize the Company’s stock options and warrants activity during the twelve months ended February 28, 2015:
				Options		Weighted Average Exercise Price	Aggregate Intrinsic Value	Exercisable	Weighted
									Average Remaining Life
	Balance, February 28, 2014			-	$	-
	Granted			38,050,000		0.11
	Expired			-		-
	Exercised			-		-
	Balance, February 28, 2015			38,050,000	$	0.11	$             -	28,050,000	4.29
	Expected future expense related to the expected vesting of options is $455,529.

Income_Tax_Provision

Income Tax Provision	12 Months Ended
	Feb. 28, 2015
Income Tax Provision
Income Tax Provision	Note 8 – Income Tax Provision
	Deferred Tax Assets
	At February 28, 2015, the Company had net operating loss (“NOL”) carry–forwards for Federal income tax purposes of $9,431,893 that may be offset against future taxable income through 2035. No tax benefit has been reported with respect to these net operating loss carry-forwards because the Company believes that the realization of the Company’s net deferred tax assets of approximately $3,092,000 was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance.
	Deferred tax assets consist primarily of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realization. The valuation allowance increased approximately $1,452,732 and $1,139,172 for the years ended February 28, 2015 and 2014, respectively.
	Components of deferred tax assets are as follows:
		28-Feb-15			28-Feb-14
	Net deferred tax assets – non-current:
	Expected income tax benefit from NOL carry-forwards	$	3,091,834		$	1,639,102
	Less valuation allowance		(3,091,834	)		(1,639,102	)
	Deferred tax assets, net of valuation allowance	$	—		$	—
	Income Tax Provision
	A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows:
		For the Fiscal Year Ended			For the Fiscal Year Ended
		February 28,			February 28,
		2015			2014
	Federal statutory income tax rate		34	%		34	%
	Change in valuation allowance on net operating loss carry-forwards		(34.0	)		(34.0	)
	Effective income tax rate		0	%		0	%

Commitments_And_Contingencies

Commitments And Contingencies	12 Months Ended
	Feb. 28, 2015
Commitments And Contingencies
Commitments and Contingencies	NOTE 9 – Commitments and Contingencies
	Litigation
	The Company may become involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, except as discussed herein, the ultimate disposition of these matters will not have a material adverse effect on the Company's financial position, results of operations, or liquidity. As of February 28, 2015, the Company is not involved in any material legal matters.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Feb. 28, 2015
Related Party Transactions
Related Party Transactions	NOTE 10 – Related Party Transactions
	In July 2014, the Company issued a note payable in the aggregate amount of $250,000 for the purchase of intellectual property from a commonly owned entity. Because of the common ownership, the intellectual property was not marked to fair value and the Company recognized a loss for the amount of the notes, which is included in loss on acquisition of intellectual property from a commonly controlled entity on the consolidated statements of operations. The note is non-interest bearing, matures in 24 months from issuance, and requires principal payments of at least $25,000 every 180 days. As of February 28, 2015, the outstanding balance as of the note was $116,337.
	In September 2014, the Company issued a note in the amount of $7,900 for cash. The note is payable in two years from issuance, and accrues interest, payable monthly, at an annual rate of 10%. The balance of the note is $7,900 as of February 28, 2015 and 2014.

Investment_In_Subsidiaries

Investment In Subsidiaries	12 Months Ended
	Feb. 28, 2015
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investment In Subsidiaries	NOTE 11 - Investment in Subsidiaries
	On November 5, 2013, the Company established three foreign (UK) subsidiaries for the exclusive purpose of maintaining merchant processing account for processing sales throughout Europe. At February 28, 2014, no sales activity had been recorded through the subsidiaries. On June 3, 2014, as a result of a change in marketing strategy, management closed out the subsidiaries.
	On January 7, 2014, the Company established one US-based subsidiary for the exclusive purpose of maintaining merchant processing accounts for processing sales throughout the US. At February 28, 2015 and 2014, no sales activity has been recorded through this subsidiary.

Subsequent_Events

Subsequent Events	12 Months Ended
	Feb. 28, 2015
Subsequent Events
Subsequent Events	NOTE 12 - Subsequent Events
	On various dates, the Company repaid principle on a third party convertible note in the amount of $38,290 in exchange for 39,750,796 shares of common stock and the note was paid in full as of March 31, 2015.
	In May 2015, a third party convertible note holder converted $48,750 in principle in exchange for 54,275,893 shares of common stock and the note was paid in full as of May 1, 2015.
	In May 2015, a third party convertible note holder converted $11,705 in principle in exchange for 38,369,856 shares of common stock.
	On various dates, the Company repaid principle on a third party convertible note in the amount of $35,000 in exchange for 59,655,167 shares of common stock and the note was paid in full as of May 15, 2015.
	On May 18, 2015, a third party lender converted $3,500 in principle in exchange for 18,396,233 shares of common stock.

Organization_And_Significant_A1

Organization And Significant Accounting Policies (Policies)	12 Months Ended
	Feb. 28, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Nature of Business
	On June 20, 2013, following a change of control and subsequent acquisition of an exclusive license agreement, certain assets and processes to innovative technologies in skin protection and enhancement, which consist of various proprietary products including an anti-aging and revitalizing skin cream generally sold under the "Radiant Creations" label, the Company changed its principal business to the development and marketing of unique and proprietary scientific technologies and cosmetic and over-the-counter personal enhancement products and devices. The Company currently sells its products exclusively over the internet to customers located globally.
Basis of Presentation	Basis of Presentation
	The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission.
Principles of Consolidation	Principles of consolidation
	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
Non-controlling Interest in Consolidated Financial Statements	Non-controlling interest in consolidated financial statements
	Accounting guidance on non-controlling interests in consolidated financial statements requires that a non-controlling interest in the equity of a subsidiary be accounted for and reported as equity and provides revised guidance on the treatment of net income and losses attributable to the non-controlling interest and changes in ownership interests in a subsidiary. The revised guidance requires additional disclosures that identify and distinguish between the interests of the controlling and non-controlling owners.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include the valuation of stock-based compensation and derivative liabilities.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis.
	As February 28, 2015:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
		$	—	$	—	$	130,103	$	130,103
	Embedded conversion derivative liability
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents
Inventory	Inventory
	Inventory consists of finished goods and is valued at the lower of cost or market value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow moving inventory is made based on management analysis or inventory levels and future sales forecasts.
Property and Equipment	Property and Equipment
	Property and equipment are stated at cost, net of depreciation provided by use of a straight-line method over the estimated useful lives of the assets, of five years. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable.
Basic and Diluted Net Loss Per Share	Basic and diluted net loss per share
	Basic loss per share is computed using the weighted average number of shares of common stock outstanding during each period. Diluted loss per share includes the dilutive effects of common stock equivalents on an “as if converted” basis. For the twelve months ended February 28, 2015, the number of potentially dilutive shares consisted of 191,333,593 shares underlying convertible debt as well as options to acquire 38,050,000 shares. For the twelve months ended February 28, 2014, the number of potentially dilutive shares consisted of 14,672,640 shares underlying the debt that was convertible as of February 28, 2014. For the years ended February 28, 2015 and 2014, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Related Parties	Related parties
	The Company follows subtopic ASC 850, Related Party Disclosure, for the identification of related parties and disclosure of related party transactions.
Revenue Recognition	Revenue Recognition
	The Company follows guidance under ASC 605, Revenue Recognition, in determining when to report income from operations. The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured. Revenue recognized by the Company normally occurs upon shipment of our product to the customer.
Cost of Revenue	Cost of Revenue
	Amounts recorded as cost of revenue relate to direct expenses incurred in order to fulfill orders of our products. Such costs are recorded as incurred. Our cost of revenue consists primarily of the cost of product; payment processing fees; and the cost of product samples.
Cash Flows Reporting	Cash flows reporting
	The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period.
Advertising	Advertising
	The Company follows guidance found under ASC 340, Other Assets and Deferred Costs, and ASC 720-35, Other Expenses – Advertising Costs, when discerning whether advertising costs should be capitalized or expensed as incurred. Although U.S. GAAP permits the allocation of advertising costs across interim periods within a fiscal year when future periods benefit from the expenditure, the Company’s policy is to expense advertising costs as incurred to eliminate the uncertainty in estimating overall expected sales volumes, advertising expenses, and the benefit period of the advertising on an interim basis due to the immateriality and nature of those costs at this time.
Share-Based Expense	Share-based Expense
	ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).
	The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.
	Share-based expense for the twelve month periods ending February 28, 2015and 2014 was $3,212,910 and $10,000, respectively.
Income Taxes	Income Taxes
	The Company utilizes the asset and liability method to measure and record deferred income tax assets and liabilities. Deferred tax assets and liabilities reflect the future income tax effects of temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and are measured using enacted tax rates that apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
	The Company follows the provisions of Accounting for Uncertainty in Income Taxes, which clarified the accounting for uncertainties in tax positions and required that the Company recognizes in its financial statements the impact of an uncertain tax position, if that position has more likely than not chance of not being sustained on audit, based on technical merits of that position.
	The Company is subject to the United States federal and state income tax examinations by the tax authorities for the 2014, 2013, and 2012 tax years.
Recently Issued Accounting Pronouncements	Recently issued accounting pronouncements
	We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operations, financial position or cash flow.
	In January 2015, FASB issued Accounting Standards Update (ASU) No. 2015-01 Income Statement—Extraordinary and Unusual Items. This Update eliminates from GAAP the concept of extraordinary items. Subtopic 225-20, Income Statement—Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions. Presently, an event or transaction is presumed to be an ordinary and usual activity of the reporting entity unless evidence clearly supports its classification as an extraordinary item. Paragraph 225-20-45-2 contains the following criteria that must both be met for extraordinary classification: 1. Unusual Nature. The underlying event or transaction should possess a high degree of abnormality and be of a type clearly unrelated to, or only incidentally related to, the ordinary and typical activities of the entity, taking into account the environment in which the entity operates. 2. Infrequency of Occurrence. The underlying event or transaction should be of a type that would not reasonably be expected to recur in the foreseeable future, taking into account the environment in which the entity operates. If an event or transaction meets the criteria for extraordinary classification, an entity is required to segregate the extraordinary item from the results of ordinary operations and show the item separately in the income statement, net of tax, after income from continuing operations. The entity also is required to disclose applicable income taxes and either present or disclose earnings-per-share data applicable to the extraordinary item.
	In August 2014, FASB issued Accounting Standards Update (ASU) No. 2014-15 Preparation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. Under generally accepted accounting principles (GAAP), continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, Presentation of Financial Statements—Liquidation Basis of Accounting. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the amendments in this Update should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company will evaluate the going concern considerations in this ASU however, for the current period, management does not believe that it has met conditions which would subject these financial statements to additional disclosure.
	In June 2014, FASB issued Accounting Standards Update (ASU) No. 2014-12 Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award’s grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after 15 December 2015 and interim periods within those annual periods. Early adoption is permitted. Management has reviewed the ASU and believes that they currently account for these awards in a manner consistent with the new guidance; therefore there is no anticipation of any effect to the financial statements.

Organization_And_Significant_A2

Organization And Significant Accounting Policies (Tables)	12 Months Ended
	Feb. 28, 2015
Organization And Significant Accounting Policies Tables
Schedule of Fair Value of Derivative Assets and Liabilities Measured on Recurring Basis	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis.
	As February 28, 2015:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
		$	—	$	—	$	130,103	$	130,103
	Embedded conversion derivative liability

Acquisition_Tables

Acquisition (Tables)	12 Months Ended
	Feb. 28, 2015
Supplemental Cash Flow Elements [Abstract]
Schedule of Assets and Liabilities Acquired	A summary of the assets and liabilities acquired are shown below:
	Purchase Price
	Stock	$	1,509,158
	Assets Acquired
	Inventory		64,530
	Nucleotide documentation		350,000
	License		1,000,000
	Convertible debentures		(370,000	)
	Promissory notes		(100,000	)
	Total value	$	944,530

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Feb. 28, 2015
Convertible Notes Payable Tables
Schedule of Convertible Notes Payable Conversion Dates and Derivative Treatment	Note	Maturity Date	Face	Eligible for Conversion	Conversion	Amounts	Balance
	Date		Amount		Date	Converted / Cash Paid*	Outstanding
	5/21/13	9/20/16	$900,448	6/15/13	N/A	$31,000*	$869,448
					9/19/13	$100,000	$769,448
					11/20/13	$70,000	$699,448
	6/27/13	- $100,000 due 12/12/2014	370,000	6/27/13	-	-	$370,000
		-$270,000 no due date
	11/19/13	8/21/14	$78,500	5/19/14	6/13/14	$12,000	$66,500
					7/1/14	$12,000	$54,500
					7/11/14	$15,000	$39,500
					7/21/14	$19,500	$20,000
			$10,000				$30,000
			Default
					11/19/14	$7,235	$22,765
					12/1/14	$5,635	$17,130
					12/12/14	$6,395	$10,735
					12/16/14	$5,780	$4,955
					1/23/15	$4,955	$ -0-
	12/17/13	9/21/14	$32,500	6/15/14	N/A	$4,430	$32,500
			$16,250			$6,030	$48,750
			Default		2/2/15		$44,320
					2/5/15		$38,290
	1/27/14	10/29/14	$32,500	7/26/14	-	-	$32,500
			$16,250				$48,750
			Default
	7/8/14	4/9/15	$21,150	1/4/15	-	-	$21,150
			$10,575				$31,725
			Default
	9/3/14	6/5/15	$32,500	3/3/15	-	-	$32,500
			$16,250				$48,750
			Default
	9/10/14	9/10/16	$35,000	9/10/14	-	-	$35,000
	1/12/15	10/14/15	$16,000	7/11/15	-	-	$16,000
			$8,000				$24,000
			Default
	Totals		$1,595,923	-	-	$299,960	$1,295,963

Derivative_Liabilities_Tables

Derivative Liabilities (Tables)	12 Months Ended
	Feb. 28, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Changes in Derivative Liabilities	The following table summarizes the changes in derivative liabilities during the twelve months ended February 28, 2015:
	Balance as of February 28, 2014	$                   -0-
	Fair value of embedded conversion derivative liability at issuance	846,833
	Reclassification of derivatives upon conversion of convertible debt	-107,172
	Unrealized derivatives gains included in other expense	-609,558
	Ending balance as of February 28, 2015	$           130,103
	The following table summarizes the changes in derivative liabilities during the twelve months ended February 28, 2014:
	Ending balance as of February 28, 2013	$                   -0-
	Additions due to new convertible debt issued	1,161,574
	Day one loss on derivative	-8,360
	Resolution of Derivative to Equity due to conversion and modification	-1,433,974
	(Gain)/loss on change in fair value	280,760
	Ending balance as of February 28, 2014	$                   -0-

Equity_Tables

Equity (Tables)	12 Months Ended
	Feb. 28, 2015
Equity Tables
Summary of Stock Option Activity	The following tables summarize the Company’s stock options and warrants activity during the twelve months ended February 28, 2015:
		Options		Weighted Average Exercise Price	Aggregate Intrinsic Value	Exercisable	Weighted
							Average Remaining Life
	Balance, February 28, 2014	-	$	-
	Granted	38,050,000		0.11
	Expired	-		-
	Exercised	-		-
	Balance, February 28, 2015	38,050,000	$	0.11	$             -	28,050,000	4.29

Income_Tax_Provision_Tables

Income Tax Provision (Tables)	12 Months Ended
	Feb. 28, 2015
Income Tax Provision Tables
Schedule of Components of Deferred Tax Assets	Components of deferred tax assets are as follows:
		28-Feb-15			28-Feb-14
	Net deferred tax assets – non-current:
	Expected income tax benefit from NOL carry-forwards	$	3,091,834		$	1,639,102
	Less valuation allowance		(3,091,834	)		(1,639,102	)
	Deferred tax assets, net of valuation allowance	$	—		$	—
Schedule of Effective Income Tax Expense Reconciliation	A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows:
		For the Fiscal Year Ended			For the Fiscal Year Ended
		February 28,			February 28,
		2015			2014
	Federal statutory income tax rate		34	%		34	%
	Change in valuation allowance on net operating loss carry-forwards		(34.0	)		(34.0	)
	Effective income tax rate		0	%		0	%

Organization_And_Significant_A3

Organization And Significant Accounting Policies (Details) (USD $)	Feb. 28, 2015
Recurring Fair Value Measures
Embedded conversion derivative liability	$130,103
Level 1
Recurring Fair Value Measures
Embedded conversion derivative liability
Level 2
Recurring Fair Value Measures
Embedded conversion derivative liability
Level 3
Recurring Fair Value Measures
Embedded conversion derivative liability	$130,103

Acquisition_Details

Acquisition (Details) (The Renewable Corporation, USD $)	0 Months Ended
	Jun. 25, 2013
The Renewable Corporation
Purchase Price
Stock	$1,509,158
Assets Acquired
Inventory	64,530
Nucleotide documentation	350,000
License	1,000,000
Convertible debentures	370,000
Promissory notes	100,000
Total value	$944,530

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)

12 Months Ended

0 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Nov. 20, 2013

Sep. 19, 2013

Jun. 15, 2013

Jun. 27, 2013

Jan. 23, 2015

Dec. 16, 2014

Dec. 12, 2014

Dec. 01, 2014

Nov. 19, 2014

Jul. 21, 2014

Jul. 11, 2014

Jul. 01, 2014

Jun. 13, 2014

Nov. 19, 2013

Nov. 19, 2013

Feb. 05, 2015

Feb. 02, 2015

Dec. 17, 2013

Jan. 27, 2014

Jul. 08, 2014

Sep. 03, 2014

Sep. 10, 2014

Jan. 12, 2015

Debt Instrument [Line Items]

Face amount

$1,595,923

Cash paid

31,000

Amount converted

299,960

Convertible Notes Payable Dated May 21, 2013

Debt Instrument [Line Items]

Note date

21-May-13

Maturity Date

20-Sep-16

Face amount

900,448

Eligible for conversion

6/15/13

Conversion date

20-Nov-13

19-Sep-13

Cash paid

31,000

Amount converted

70,000

100,000

Balance outstanding

699,448

769,448

869,448

Convertible Notes Payable Dated June 27, 2013

Debt Instrument [Line Items]

Note date

27-Jun-13

Maturity Date Description

-$100,000 due 12/12/2014 -$270,000 no due date

Face amount

370,000

Eligible for conversion

6/27/13

Amount converted

Balance outstanding

370,000

Convertible Notes Payable Dated November 19, 2013

Debt Instrument [Line Items]

Note date

19-Nov-13

Maturity Date

21-Aug-14

21-Aug-14

Face amount

78,500

78,500

Eligible for conversion

5/19/14

Conversion date

23-Jan-15

16-Dec-14

12-Dec-14

1-Dec-14

19-Nov-14

21-Jul-14

11-Jul-14

1-Jul-14

13-Jun-14

Amount converted

4,955

5,780

6,395

5,635

7,235

19,500

15,000

12,000

12,000

Balance outstanding

4,955

10,735

17,130

22,765

20,000

39,500

54,500

66,500

Convertible Notes Payable Dated November 19, 2013

Debt Instrument [Line Items]

Note date

19-Nov-14

Face amount

10,000

10,000

Balance outstanding

30,000

30,000

Convertible Notes Payable Dated December 17, 2013

Debt Instrument [Line Items]

Note date

17-Dec-13

Maturity Date

21-Sep-14

Face amount

32,500

Eligible for conversion

6/15/14

Amount converted

6,030

4,430

Balance outstanding

38,290

38,290

44,320

32,500

Convertible Notes Payable Dated December 17, 2013

Debt Instrument [Line Items]

Face amount

16,250

Balance outstanding

48,750

Convertible Notes Payable Dated January 27, 2014

Debt Instrument [Line Items]

Note date

27-Jan-14

Maturity Date

29-Oct-14

Face amount

32,500

Eligible for conversion

7/26/14

Balance outstanding

48,750

32,500

Convertible Notes Payable Dated January 27, 2014

Debt Instrument [Line Items]

Face amount

16,250

Balance outstanding

48,750

Convertible Notes Payable Dated July 08, 2014

Debt Instrument [Line Items]

Note date

8-Jul-14

Maturity Date

9-Apr-15

Face amount

21,150

Eligible for conversion

1/4/15

Balance outstanding

31,275

21,150

Convertible Notes Payable Dated July 08, 2014

Debt Instrument [Line Items]

Face amount

10,575

Balance outstanding

31,725

Convertible Notes Payable Dated September 03, 2014

Debt Instrument [Line Items]

Note date

3-Sep-14

Maturity Date

5-Jun-15

Face amount

32,500

Eligible for conversion

3/3/15

Balance outstanding

48,750

32,500

Convertible Notes Payable Dated September 03, 2014

Debt Instrument [Line Items]

Face amount

16,250

Balance outstanding

48,750

Convertible Notes Payable Dated September 10, 2014

Debt Instrument [Line Items]

Note date

10-Sep-14

Maturity Date

10-Sep-16

Face amount

35,000

Eligible for conversion

9/1/14

Balance outstanding

35,000

Convertible Notes Payable Dated January 12, 2015

Debt Instrument [Line Items]

Note date

12-Jan-15

Maturity Date

14-Oct-15

Face amount

16,000

Eligible for conversion

7/11/15

Balance outstanding

24,000

16,000

Convertible Notes Payable Dated January 12, 2015

Debt Instrument [Line Items]

Face amount

8,000

Balance outstanding

$24,000

Derivative_Liabilities_Details

Derivative Liabilities (Details) (Derivative Liabilities, USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Derivative Liabilities
Derivative Liabilities:
Opening Balance	$0	$0
Additions due to new convertible debt issued		1,161,574
Day one loss on derivative		-8,360
Fair value of embedded conversion derivative liability at issuance	846,833
Reclassification of derivatives upon conversion of convertible debt	-107,172	-1,433,974
Unrealized derivatives gains included in other expense	-609,558
(Gain)/loss on change in fair value		280,760
Ending balance	$130,103	$0

Equity_Details

Equity (Details) (USD $)	12 Months Ended
	Feb. 28, 2015
Number of Options
Balance, February 28, 2014
Granted	38,050,000
Expired
Exercised
Balance, February 28, 2015	38,050,000
Weighted Average Exercise Price
Balance, February 28, 2014
Granted	$0.11
Expired
Exercised
Balance, November 30, 2014	$0.11
Aggregate Intrinsic Value
Exercisable	28,050,000
Weighted Average Remaining Life	4 years 3 months 14 days

Income_Tax_Provision_Schedule_

Income Tax Provision (Schedule Of Components Of Deferred Tax Assets) (Details) (USD $)	Feb. 28, 2015	Feb. 28, 2014
Net deferred tax assets b non-current:
Expected income tax benefit from NOL carry-forwards	$3,091,834	$1,639,102
Less valuation allowance	3,091,834	1,639,102
Deferred tax assets, net of valuation allowance

Income_Tax_Provision_Schedule_1

Income Tax Provision (Schedule Of Effective Income Tax Expense Reconciliation) (Details)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Income Tax Provision Schedule Of Effective Income Tax Expense Reconciliation Details
Federal statutory income tax rate	34.00%	34.00%
Change in valuation allowance on net operating loss carry-forwards	-34.00%	-34.00%
Effective income tax rate	0.00%	0.00%

Organization_And_Significant_A4

Organization And Significant Accounting Policies (Narrative) (Details) (Convertible Debenture)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Convertible Debenture
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	191,333,593	14,672,640

Going_Concern_Narrative_Detail

Going Concern (Narrative) (Details) (USD $)	Feb. 28, 2015
Going Concern Narrative Details
Working capital deficit	$1,025,221

Acquisition_Narrative_Details

Acquisition (Narrative) (Details) (USD $)	12 Months Ended		0 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Jul. 10, 2013	Jun. 25, 2013
Noncash or Part Noncash Acquisitions [Line Items]
Excess fair value of asset purchase- compensation		$564,628
The Renewable Corporation
Noncash or Part Noncash Acquisitions [Line Items]
Shares issued for acquisition of assets				6,805,556
Purchase price of assets acquired, price per share			$0.20	$0.20
Increase in number of shares issued for acquisition of assets			7,545,788
Excess fair value of asset purchase- compensation				$564,628

Notes_Payable_Narrative_Detail

Notes Payable (Narrative) (Details) (USD $)	12 Months Ended		0 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Jul. 31, 2014	Oct. 31, 2014	Feb. 03, 2014	Feb. 28, 2014	Jul. 31, 2014	Sep. 30, 2014
Debt Instrument [Line Items]
Note payable	$135,000	$95,000				$95,000
Advance from related party	12,493	153,250
Proceeds from notes payable	50,000
Payments on related party notes	129,986	87,600
Notes Payable Issued In July 2014
Debt Instrument [Line Items]
Interest rate on debt			10.00%				10.00%
Proceeds from notes payable			40,000
Debt instrument maturity description			The note matures in 36 months.
Notes Payable Issued In October 2014
Debt Instrument [Line Items]
Interest rate on debt				12.00%
Debt instrument terms				The note is due on demand.
Proceeds from notes payable				50,000
Notes Payable | Corporate Officers
Debt Instrument [Line Items]
Interest rate on debt					15.00%
Debt instrument maturity date					28-Feb-15
Advance from related party					50,000	15,650
Debt instrument terms						The advances were non-interest bearing and due on demand
Notes Payable For Purchase Of Intellectual Property | Commonly Controlled Entity
Debt Instrument [Line Items]
Note payable	116,337
Debt instrument terms							The note is non-interest bearing, matures in 24 months from issuance, and requires principal payments of at least $25,000 every 180 days.
Notes payable issued							250,000
Notes Payable Issued In September 2014 | Related Party
Debt Instrument [Line Items]
Note payable	7,900
Interest rate on debt								10.00%
Proceeds from notes payable								7,900
Debt instrument maturity description								The note is payable in two years from issuance
Notes Payable - Third Parties
Debt Instrument [Line Items]
Note payable	75,000
Interest rate on debt	15.00%
Debt instrument maturity date	29-Nov-14
Notes Payable - Third Parties
Debt Instrument [Line Items]
Note payable	$10,000
Interest rate on debt	15.00%
Debt instrument maturity date	31-Jan-15

Convertible_Notes_Payable_Narr

Convertible Notes Payable (Narrative) (Details) (USD $)

12 Months Ended

36 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

2 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2013

Nov. 29, 2013

Feb. 24, 2014

Nov. 19, 2013

Nov. 19, 2013

Dec. 02, 2014

Jun. 25, 2014

Dec. 17, 2013

Jul. 26, 2014

Jan. 27, 2014

Jan. 04, 2015

Jul. 08, 2014

Mar. 02, 2015

Sep. 03, 2014

Sep. 09, 2014

Jul. 11, 2015

Jan. 12, 2015

Oct. 31, 2014

Nov. 30, 2014

18-May-14

Jan. 23, 2015

Dec. 16, 2014

Dec. 12, 2014

Dec. 01, 2014

Nov. 19, 2014

Jul. 21, 2014

Jul. 11, 2014

Jul. 01, 2014

Jun. 13, 2014

Feb. 05, 2015

Feb. 02, 2015

Debt Instrument [Line Items]

Debt instrument face amount

$1,595,923

Unamortized debt discount

507,211

Proceeds from convertible notes payable

110,440

143,500

Accrued interest

171,908

74,358

Notes carrying value

788,752

Convertible Notes Payable - Two Third Party

Debt Instrument [Line Items]

Debt instrument maturity date

20-Sep-15

Repayment on notes

-31,000

Unamortized debt discount

252,313

Proceeds from convertible notes payable

720,000

Convertible notes payable

699,448

Debt conversion original debt amount

-900,448

Accrued interest portion of debt converted

-140,448

Convertible Notes Payable - Southwest Financial

Debt Instrument [Line Items]

Interest rate on debt

10.00%

Debt conversion price per share

$0.00

$0.08

Debt instrument conversion terms

The convertible note was convertible at a variable rate of 50% of the lowest prior three trading days.

The convertible notes were convertible at the option of the Holder at a rate of 50% of the average of the previous 5 days closing price on the common stock.

Debt conversion original debt amount

170,000

730,448

900,448

Accrued interest portion of debt converted

57,132

140,448

Convertible Notes Payable - Southwest Financial | Common Stock

Debt Instrument [Line Items]

Stock issued in conversion of debt, shares

32,005,054

Debt conversion original debt amount

215,150

Convertible Notes Payable - Third Party

Debt Instrument [Line Items]

Debt instrument face amount

370,000

370,000

Interest rate on debt

10.00%

10.00%

Debt conversion price per share

$0.08

$0.08

Unamortized debt discount

148,771

Convertible notes payable

370,000

Accrued interest

4,041

4,041

Convertible Notes Payable Dated November 19, 2013

Debt Instrument [Line Items]

Debt instrument face amount

78,500

78,500

Interest rate on debt

8.00%

8.00%

Debt instrument maturity date

21-Aug-14

21-Aug-14

Unamortized debt discount

64,146

Convertible notes payable

4,955

10,735

17,130

22,765

20,000

39,500

54,500

66,500

Debt instrument conversion terms

The note was convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Convertible Notes Payable Dated November 19, 2013 | Common Stock

Debt Instrument [Line Items]

Stock issued in conversion of debt, shares

10,540,476

Debt conversion original debt amount

78,500

Default interest portion of debt converted

10,000

Convertible Notes Payable Dated December 17, 2013

Debt Instrument [Line Items]

Debt instrument face amount

32,500

Interest rate on debt

8.00%

Debt instrument maturity date

21-Sep-14

Unamortized debt discount

25,723

Convertible notes payable

38,290

32,500

38,290

44,320

Debt instrument conversion terms

The note became convertible and the embedded conversion option required derivative accounting for the variable conversion rate.

The note is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Default interest portion of debt converted

16,250

Convertible Notes Payable Dated December 17, 2013 | Common Stock

Debt Instrument [Line Items]

Stock issued in conversion of debt, shares

8,716,667

Debt conversion original debt amount

10,460

Convertible Notes Payable Dated January 27, 2014

Debt Instrument [Line Items]

Debt instrument face amount

32,500

Interest rate on debt

8.00%

Debt instrument maturity date

29-Oct-14

Unamortized debt discount

23,228

Convertible notes payable

48,750

32,500

Debt instrument conversion terms

The note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate.

The note is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Default interest

16,250

Derivative liability

11,014

Convertible Notes Payable Dated July 08, 2014

Debt Instrument [Line Items]

Debt instrument face amount

21,150

Interest rate on debt

8.00%

Debt instrument maturity date

9-Apr-15

Unamortized debt discount

11,138

Convertible notes payable

31,275

21,150

Debt instrument conversion terms

The note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate.

The note is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Default interest

10,575

Derivative liability

7,136

Convertible Notes Payable Dated September 03, 2014

Debt Instrument [Line Items]

Debt instrument face amount

32,500

Interest rate on debt

8.00%

Debt instrument maturity date

5-Jun-15

Convertible notes payable

48,750

32,500

Debt instrument conversion terms

The note became convertible and the embedded conversion option will require derivative accounting due to the variable conversion rate.

The note is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Default interest

16,250

Derivative liability

9,264

Convertible Notes Payable Dated September 09, 2014

Debt Instrument [Line Items]

Debt instrument face amount

200,000

Interest rate on debt

12.00%

Debt conversion price per share

$0.05

Convertible notes payable

38,500

Debt instrument conversion terms

The conversion price is the lesser of $0.045 or 60% of the lowest trade price in the 25 trading days previous to the conversion.

Debt maturity date description

The Maturity Date is two years from the Effective Date of each payment and is the date upon which the principal sum of this Note, as well as any unpaid interest and other fees, shall be due and payable.

Debt instrument terms

The principle amount due on the note shall be prorated based upon the consideration actually received by the Company, plus an approximate 10% original issue discount that is prorated based upon the consideration actually received as well as any other interest or fees. Under the terms of the note, the Company is not required to repay any unfunded portion of the note.

Convertible Notes Payable Dated January 12, 2015

Debt Instrument [Line Items]

Debt instrument face amount

16,000

Interest rate on debt

8.00%

Debt instrument maturity date

14-Oct-15

Convertible notes payable

24,000

16,000

Debt instrument conversion terms

The note became convertible and the embedded conversion option required derivative accounting to the variable conversion rate.

The note is convertible into the Company’s common stock after 180 days from the date of issuance at 58% of the average of the lowest prices of the common stock during the ten days preceding the date of conversion.

Default interest

8,000

Derivative liability

4,636

Convertible Liability With Certain Individuals

Debt Instrument [Line Items]

Debt instrument face amount

240,000

Interest rate on debt

0.00%

Debt instrument conversion terms

The Holder has the right to convert all or any part of the outstanding and unpaid principal into shares of the Company’s common stock. On October 2016, 2014, the US Court ordered approval of the liability triggered derivative treatment. The Holders have the right from and after the court ordered dated, and until any time until the Liability is fully paid, to convert any outstanding and unpaid principal portion of the Liability, into fully paid and non-assessable shares of Common Stock. The Convertible Liability is convertible at variable conversion prices at 55% of lowest trading prices over 15 trading days with no reset provisions.

Stock issued in conversion of debt, shares

3,740,000

Debt conversion original debt amount

19,524

Derivative liability

253,401

Derivative liability expenses

$253,401

Derivative_Liabilities_Narrati

Derivative Liabilities (Narrative) (Details)	12 Months Ended				9 Months Ended	12 Months Ended
	Feb. 28, 2015			Feb. 28, 2014	Nov. 29, 2013	Feb. 24, 2014
Fair Value Assumptions - Multinomial Lattice Model:
Valuation model used in determining fair value of derivative liabilities	Multinomial Lattice Model			Multinomial Lattice Model
Fair value measurement assumptions	The fair value of the instruments was determined using multinomial lattice model based on the following assumptions:			The fair value of the instruments was determined using multinomial lattice model based on the following assumptions:
		-	The projected volatility curve for each valuation period was based on the historical volatility of the Company and ranged from 191% to 198%.	-  The projected volatility curve for each valuation period was based on the historical volatility of the Company.
				-  1 to 5-year Volatility 198%-431%,
		-	An event of default would occur 5% of the time, increasing 1.00% per month to a maximum of 10%,	-  An event of default would occur 5% of the time, increasing 1.00% per month to a maximum of 10%,
				-  The monthly trading volume would average $100,000 to $135,600 and would increase at 1% per month. The variable conversion prices 50% of ask-bid or close prices over 3 to 10 trading days have effective discount rates of 31.75% to 49.13%,
		-	The monthly trading volume would average $175,000 to $136,000 and would increase at 1% per month. The variable conversion price of 58% of ask-bid or close prices over 10 trading days have an effective discount rates of 42.42%,	-  The Note Holders would automatically convert variable conversion prices 50% of ask-bid or close prices over 3 to 10 (with full ratchet resets) the notes at the stock price for the Convertible Note if the registration was effective and the Company was not in default, and Conversion price reset events are assumed every 3 months.
		-	The variable conversion price of the lesser of: (i) $0.045, or (ii) 60% of the lowest trade price over 25 trading days would have an effective discount rates of 47.92% to 47.64%
		-	The Note Holders would automatically convert fixed and variable conversion prices (with full ratchet resets) the notes at the stock price for the convertible Note if the registration was effective and the Company was not in default, and conversion price reset events are assumed every 3 months.
Convertible Notes Payable - Southwest Financial
Fair Value Assumptions - Multinomial Lattice Model:
Debt conversion terms					The convertible note was convertible at a variable rate of 50% of the lowest prior three trading days.	The convertible notes were convertible at the option of the Holder at a rate of 50% of the average of the previous 5 days closing price on the common stock.
Minimum
Fair Value Assumptions - Multinomial Lattice Model:
Volatility rate				198.00%
Maximum
Fair Value Assumptions - Multinomial Lattice Model:
Volatility rate				431.00%

Equity_Narrative_Details

Equity (Narrative) (Details) (USD $)	12 Months Ended		36 Months Ended	0 Months Ended		1 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2013	Oct. 10, 2014	Oct. 13, 2014	Oct. 13, 2014
Proceeds from contributed capital		$2,000
Common stock repurchased, value		1,030,000
Preferred stock authorized, shares	100,000,000
Intellectual property description	The Company estimated the fair value of the 20,000,000 shares of common stock based on the trading price on date of the exchange, and the fair value of the preferred stock using a probability weighted expected return method (PWERM) and recorded expense equal to the excess of the fair value of the preferred stock over the common stock of $476,400, which is included in loss on acquisition of intellectual property from a commonly controlled entity on the condensed consolidated statements of operations.
No of stock options granted	38,050,000
Exercise price of options	$0.11
Stock compensation expense	3,212,910	10,000
Fair value assumptions of options and warrants - Black Scholes Model
Volatility rate, minimum	188.00%
Volatility rate, maximum	288.00%
Risk Free interest rate, minimum	0.38%
Risk Free interest rate, maximum	0.94%
Expected future expense	455,529
Stock Options
No of stock options granted	38,050,000
Stock option terms	5 years
No of options vested immediately	10,000,000
Vesting terms of options and warrants	10,000,000 options vested immediately while the remaining 28,050,000 options vest at a rate of 33% on the grant date, 33% one year from the grant date and the remaining 33% two years from the grant date.
Fair value of options vested	4,502,234
Stock compensation expense	3,193,006
Valuation model used in determining fair value of options	Black Scholes model
Convertible Notes Payable - Southwest Financial
Debt conversion price per share	$0.00	$0.08
Stock issued in conversion of debt, value	170,000	730,448	900,448
Preferred Shares Series A
Preferred stock, shares issued	1,000,000	0
Preferred stock authorized, shares				1,000,000
Preferred stock voting rights				Holders of each Series A Preferred Stock shall have two hundred (200) times the number of votes on all matters submitted to the shareholders that each shareholder of the Corporation’s Common Stock (rounded to the nearest whole number) is entitled to vote at each meeting of the shareholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the shareholders of the Corporation for their action or consideration. Holders of the Series A Preferred Stock shall vote together with the holders of Common Stock as a single class.
Series B Preferred Stock
Preferred stock, shares issued	20,000,000	0
Preferred stock authorized, shares					20,000,000	20,000,000
Preferred stock voting rights					Except as specifically provided, the Series B Preferred Stock shall, with respect to rights on redemption and rights on liquidation, winding up and dissolution, rank senior to (i) all classes of Common Stock, $0.00001 par value per share, of the Company (the “Common Stock”) and (ii) any class or series of capital stock of the Company hereafter created (unless, with the consent of the Holder(s) of Series B Preferred Stock). All other provisions remain pari passu as to the Company's common stock.
Biodynamic Molecular Technologies, LLC | Preferred Shares Series A
Preferred stock, shares issued					1,000,000	1,000,000
Biodynamic Molecular Technologies, LLC | Series B Preferred Stock
Preferred stock, shares issued					20,000,000	20,000,000
Minimum | Stock Options
Exercise price of options	$0.10
Maximum | Stock Options
Exercise price of options	$0.13
Common Stock
Stock issued price per share		$0.05
Common stock repurchased, shares		-7,545,788
Common stock repurchased, value		75
Cancellation of common shares, shares	-20,000,000
Common Stock | Convertible Notes Payable - Southwest Financial
Stock issued in conversion of debt, shares	32,005,054
Stock issued in conversion of debt, value	215,150
Common Stock | Biodynamic Molecular Technologies, LLC
Cancellation of common shares, shares						20,000,000
Common Stock | Conversion Of Debt
Debt conversion price per share		$0.05
Stock issued in conversion of debt, shares		2,933,333
Stock issued in conversion of debt, value		170,000
Common Stock | Conversion Of Accounts Payable
Stock issued in conversion of debt, shares		480,564
Common Stock | Conversion Of Accounts Payable | Minimum
Debt conversion price per share		$0.05
Common Stock | Conversion Of Accounts Payable | Maximum
Debt conversion price per share		$0.10
Common Stock | The Renewable Corporation
Common stock repurchased, shares		7,545,788
Common stock repurchased, value		1,030,000
Common Stock | Former CEO
Proceeds from contributed capital		$2,000

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Income Taxes Narrative Details
Net operating loss carryforward	$9,431,893
Increase in valuation allowance	$1,452,732	$1,139,172

Subsequent_Events_Narrative_De

Subsequent Events (Narrative) (Details) (Subsequent Event, Common Stock, Conversion Of Third Party Notes, USD $)	0 Months Ended	1 Months Ended		3 Months Ended
	18-May-15	31-May-15	Mar. 31, 2015	15-May-15
Conversion Of Third Party Notes
Subsequent Event [Line Items]
Stock issued in conversion of debt, value	$3,500	$48,750	$38,290	$35,000
Stock issued in conversion of debt, shares	18,396,233	54,275,893	39,750,796	59,655,167
Conversion Of Third Party Notes
Subsequent Event [Line Items]
Stock issued in conversion of debt, value		$11,705
Stock issued in conversion of debt, shares		38,369,856